Uganda Will Harvest the DNA of its Citizens Under National ID Program

The East African nation of Uganda is announcing plans to begin harvesting and tracking the DNA and biometric data of its citizens under an updated version of the country’s national ID program, which will see genetic information added to the ID cards that Ugandans are legally required to obtain.

Uganda began its national ID program in 2014, giving the cards a 10-year lifespan before they reach expiration.  Under plans recently announced by the nation’s government, when cards start expiring in 2024, Uganda will begin to harvest the DNA of its citizens for use in the revamped national ID program, though it isn’t clear exactly how the government plans to extract the DNA from its citizens.

In addition to information on Ugandan’s DNA profiles, the updated ID cards will feature biometric data and fingerprints, as well as information gathered from the eyes of Ugandan citizens using scan technology. All this, the government says, will help speed up the identity verification process at government offices and administrative centers, as well as assist law enforcement in their investigations. The cards are also digitized, giving the government instant access to citizens’ information via a massive national catalog.

Keep reading

FDA Says CRISPR Gene-Edited Cattle Safe for Human Consumption

The U.S. Food and Drug Administration (FDA) has determined that short-haired cattle produced through CRISPR gene-editing technology are safe for human consumption. The cattle, known as PRLR-SLICK, were the first to receive an FDA “low-risk determination for enforcement discretion” after the agency determined the intentional genomic alteration (IGA) of the two genome-edited cattle does not raise any safety concerns.

Produced by Acciligen with climate change in mind, the cows have a genetic trait that gives them a short, sleek coat which is said to help the animals cope with hot weather more effectively. The FDA’s low-risk determination means the agency does not expect Acciligen, a “precision breeding” company, to seek regulatory approval before marketing products from the cattle.

The FDA spent years reviewing the two other genetically altered animals approved for human consumption—a faster-growing salmon and a pig the agency determined was safe for consumption by people with meat allergies. However, the review process for the CRISPR beef cattle took less than a year because the FDA noted the gene-editing results in the same slick-hair trait seen in cattle that are found in conventional agriculture. Talking about the Mar. 7, 2022 approval, Steven Solomon, director of the FDA Center for Veterinary Medicine, said:

“We expect that our decision will encourage other developers to bring animal biotechnology products forward for the FDA’s risk determination in this rapidly developing field, paving the way for animals containing low-risk IGAs (intentional genomic alterations) to more efficiently reach the marketplace.”

Looking closer at Acceligen, the company website says that most of its workers have backgrounds in the farm industry. The company explains that “precision breeding” is different from conventional breeding or genetically modified organisms (GMO) in that it allows a “highly desired trait” that may typically take years to show up to be expressed in “just one breeding cycle.”  

Keep reading

Scientific Study confirms Pfizer’s COVID Vaccine alters Human DNA

A Swedish study has demonstrated and confirmed that the mRNA in the Pfizer/BioNTech Covid injections infiltrates cells and transcribes its message onto human DNA within 6 hours, altering our own DNA. 

A previous study published in October 2021 from Sweden found the spike protein enters into our cells’ nuclei and impairs the mechanism our cells have to repair damaged DNA. We’ve included this study here as The Highwire made an easy-to-understand video explaining it, including graphics, and so it is a good starting point to help understand the significance of the latest study from Sweden.

Keep reading

Forget extinction: U.S. company plans to bring back wooly mammoths

Wooly mammoths might be making a comeback thanks to Colossal Biosciences of the great state of Texas.

The Dallas-based company says it plans to take on the environmental issues that led to critical endangerment and perform the once seemingly impossible task of reviving long-extinct species.

Colossal announced it will pioneer the use of CRISPR technology along with other genome engineering technologies toward a practical working model of de-extinction initially focused on its long-term goals of successful restoration and rewilding of functional woolly mammoths, large proboscideans from the Ice Age, to the tundra, according to a press release.

It said genetic engineering applications expand beyond animals and have the potential to advance human health, enhance food production, reduce environmental impact, and optimize animal health and welfare.

Keep reading

Mosquitoes With Synthetic DNA Scheduled For California Release

In the mosquito breeding rooms of British biotech company Oxitec, scientists line up fresh eggs, each the size of a grain of salt. Using microscopic needles, the white-coated researchers inject each egg with a dab of a proprietary synthetic DNA.

For four days, Oxitec technicians care for the eggs, watching for those that hatch into wriggling brown larvae. Those “injection survivors,” as the company calls them, face a battery of tests to ensure their genetic modification is successful.

Soon, millions of these engineered mosquitoes could be set loose in California in an experiment recently approved by the federal government.

Oxitec, a private company, says its genetically modified bugs could help save half the world’s population from the invasive Aedes aegypti mosquito, which can spread diseases such as yellow fever, chikungunya and dengue to humans. Female offspring produced by these modified insects will die, according to Oxitec’s plan, causing the population to collapse.

“Precise. Environmentally sustainable. Non-toxic,” the company says on its website of its product trademarked as the “Friendly” mosquito.

Scientists independent from the company and critical of the proposal say not so fast. They say unleashing the experimental creatures into nature has risks that haven’t yet been fully studied, including possible harm to other species or unexpectedly making the local mosquito population harder to control.

Even scientists who see the potential of genetic engineering are uneasy about releasing the transgenic insects into neighborhoods because of how hard such trials are to control.

“There needs to be more transparency about why these experiments are being done,” said Natalie Kofler, a bioethicist at Harvard Medical Schoolwho has followed the company’s work. “How are we weighing the risks and benefits?”

Keep reading

More evidence Covid was tinkered with in a lab? Now scientists find virus contains tiny chunk of DNA that matches sequence patented by Moderna THREE YEARS before pandemic began

Fresh suspicion that Covid may have been tinkered with in a lab emerged today after scientists found genetic material owned by Moderna in the virus’s spike protein.

They identified a tiny snippet of code that is identical to part of a gene patented by the vaccine maker three years before the pandemic.   

It was discovered in SARS-CoV-2’s unique furin cleavage site, the part that makes it so good at infecting people and separates it from other coronaviruses.

The structure has been one of the focal points of debate about the virus’s origin, with some scientists claiming it could not have been acquired naturally.  

The international team of researchers suggest the virus may have mutated to have a furin cleavage site during experiments on human cells in a lab.

They claim there is a one-in-three-trillion chance Moderna’s sequence randomly appeared through natural evolution. 

But there is some debate about whether the match is as rare as the study claims, with other experts describing it as a ‘quirky’ coincidence rather than a ‘smoking gun’. 

Keep reading

CDC finally admits, casually, that covid nasal “testing” swabs were used to sequence people’s genomes for analysis

The nation’s top “public health” agency has casually admitted that Wuhan coronavirus (Covid-19) nasal swabs are being used to sequence people’s genomes, and not necessarily to test for covid.

According to the U.S. Centers for Disease Control and Prevention (CDC), many of the cotton swab sticks that are being jammed up people’s nasal cavities and processed with a fraudulent PCR test are later collected and used by “scientists” to conduct “research” on people’s gene profiles. (Related: These same nasal swabs also punctured some people’s brain membranes, causing them to leak spinal fluid.)

“Remember that COVID-19 nose swab test you took? What happened to the swab? If it was processed with a PCR test, there’s a 10 percent chance that it ended up in a lab for genomic sequencing analysis,” the CDC announced on Twitter.

Keep reading

China Creating ‘Humanized Pigs’ with Gene Editing Then Infecting Them with Coronavirus

China’s state-run Global Times newspaper celebrated on Thursday the alleged discovery of a scientific process to create a “humanized pig” more susceptible to severe Chinese coronavirus cases, which scientists could infect and use for research.

The propaganda outlet attributed the scientific achievement to the Institute of Microbiology of the Chinese Academy of Sciences (IMCAS). The CAS, a research institution, is the world’s largest organization of its kind and a formal arm of the Chinese government. The Times published an illustrative figure on the development of “humanized” pigs that appears to have first surfaced in a study published in August that promoted the use of genetically modified pigs for Chinese coronavirus research based on how rapidly scientists could generate them and their heightened similarities with the human body.

The August study – published in Cell Discovery, a journal sponsored by the CAS, revealed that Chinese scientists had attempted to use CRISPR gene-editing technology to remove the genetic protective shields that make Chinese coronavirus not a significant threat to most pigs. CRISPR technology became the source of global controversy in 2018 after a Chinese scientist, He Jiankui, claimed to have used the method to genetically modify unborn baby twins to make them immune to HIV. The Communist Party sentenced He to three years in prison for conducting the human experiment without the full approval of the Party.

Keep reading